Brasier, Noé https://orcid.org/0000-0003-0186-0865
Wang, Joseph https://orcid.org/0000-0002-4921-9674
Gao, Wei https://orcid.org/0000-0002-8503-4562
Sempionatto, Juliane R.
Dincer, Can https://orcid.org/0000-0003-3301-1198
Ates, H. Ceren https://orcid.org/0000-0001-7882-4745
Güder, Firat
Olenik, Selin
Schauwecker, Ivo
Schaffarczyk, Dietmar
Vayena, Effy https://orcid.org/0000-0003-1303-5467
Ritz, Nicole
Weisser, Maja
Mtenga, Sally
Ghaffari, Roozbeh
Rogers, John A. https://orcid.org/0000-0002-2980-3961
Goldhahn, Jörg https://orcid.org/0000-0003-0012-0494
Article History
Received: 7 August 2023
Accepted: 18 October 2024
First Online: 4 December 2024
Competing interests
: R.G. is co-founder and CEO of Epicore Biosystems. J.W. is founder and chief scientific officer at Persperion. W.G. is co-founder and advisor at Persperity Health. E.V. serves in the ethics advisory panel of Merck AG and in the ethics advisory panel of IQVIA. J.A.R. is a co-founder and advisor to Sibel Health, Sonica and Epicore Biosystems, and holds patents associated with these companies. The other authors declare no competing interests.